(Q46908254)

26 December 2017

title

Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients (English)

1 reference

26 December 2017

1 reference

4

Atsushi Takahashi

1 reference

26 December 2017

author name string

Taisei Mushiroda

1

1 reference

26 December 2017

Yozo Ohnishi

2

1 reference

26 December 2017

Susumu Saito

3

1 reference

26 December 2017

Yuka Kikuchi

5

1 reference

26 December 2017

Shigeru Saito

6

1 reference

26 December 2017

Hideki Shimomura

7

1 reference

26 December 2017

Yasuhiko Wanibuchi

8

1 reference

26 December 2017

Takao Suzuki

9

1 reference

26 December 2017

Naoyuki Kamatani

10

1 reference

26 December 2017

Yusuke Nakamura

11

1 reference

26 December 2017

publication date

24 January 2006

1 reference

26 December 2017

Journal of Human Genetics

published in

1 reference

26 December 2017

volume

51

1 reference

26 December 2017

issue

3

1 reference

26 December 2017

page(s)

249-253

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1007/s10038-005-0354-5

exact match

0 references

cites work

Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10038-005-0354-5

Novel CYP2C9 genetic variants in Asian subjects and their influence on maintenance warfarin dose

21 January 2018

1 reference

12 December 2020

Genetic polymorphism of cytochrome P450s, CYP2C19, and CYP2C9 in a Japanese population

1 reference

12 December 2020

Catalog of 320 single nucleotide polymorphisms (SNPs) in 20 quinone oxidoreductase and sulfotransferase genes

1 reference

12 December 2020

Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective

1 reference

12 December 2020

Identification of the gene for vitamin K epoxide reductase

1 reference

12 December 2020

Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients

1 reference

12 December 2020

A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity.

1 reference

12 December 2020

Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions

1 reference

12 December 2020

Clinical consequences of cytochrome P450 2C9 polymorphisms

1 reference

12 December 2020

Rapid reverse transcription-PCR detection of hepatitis C virus RNA in serum by using the TaqMan fluorogenic detection system

1 reference

12 December 2020

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

1 reference

12 December 2020

Common VKORC1 and GGCX polymorphisms associated with warfarin dose

1 reference

12 December 2020

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

1 reference

12 December 2020

Anticoagulant therapy in Japanese patients with mechanical mitral valves.

1 reference

12 December 2020

A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin.

1 reference

12 December 2020

A high-throughput SNP typing system for genome-wide association studies

1 reference

12 December 2020

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

1 reference

12 December 2020

Pharmacodynamic resistance to warfarin associated with a Val66Met substitution in vitamin K epoxide reductase complex subunit 1.

1 reference

12 December 2020

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

1 reference

12 December 2020

10.1007/S10038-005-0354-5

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017